Circulating cytokine pattern and factors describing rheumatoid arthritis: IL-15 as one of the biomarkers for RA

Biomarkers

Volumn 17, Issue 7, 2012, Pages 655-662

  Pavkova Goldbergova, Monika ^a   Pavek, Nikolas ^a   Lipkova, Jolana ^a   Jarkovsky, Jiri ^a   Stouracova, Martina ^b   Gatterova, Jindra ^c   Vasku, Anna ^a   Soucek, Miroslav ^b   Nemec, Petr ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Circulating level; Cytokine; Interleukin; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-15; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; ROC CURVE; YOUNG ADULT;

EID: 84867925347     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.719036     Document Type: Article

References (43)

1. Afzali B, Lombardi G, Lechler RI, Lord GM. (2007). The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32-46.
2. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. (1995). IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483-490.
3. Badolato R, Ponzi AN, Millesimo M, Notarangelo LD, Musso T. (1997). Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90:2804-2809.
4. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. (1994). The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940-4944.
5. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, Parren PW, Gracie JA, Jongbloed S, Liew FY, McInnes IB. (2005). Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum 52:2686-2692.
6. Becknell B, Caligiuri MA. (2005). Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 86:209-239.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
8. Brennan FM, Maini RN, Feldmann M. (1998). Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol 20:133-147.
9. Brombacher F. (2000). The role of interleukin-13 in infectious diseases and allergy. Bioessays 22:646-656.
10. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. (2006). IL-15/IL-15 receptor biology: A guided tour through an expanding universe. Cytokine Growth Factor Rev 17:259-280.
11. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA. (1997). A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99:937-943.
12. Celis R, Planell N, Fernádez-Sueiro JL, Sanmartí R, Ramírez J, González-Álvaro I, Pablos JL, Cañete JD. (2012). Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features. Arthritis Res Ther 14:R93.
13. Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440.
14. Gaffen SL. (2004). Biology of recently discovered cytokines: interleukin-17-a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther 6:240-247.
15. Goldring SR. (2003). Inflammatory mediators as essential elements in bone remodeling. Calcif Tissue Int 73:97-100.
16. Harris KM. (2011). Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J Leukoc Biol 90:727-734.
17. Hoontrakoon R, Chu HW, Gardai SJ, Wenzel SE, McDonald P, Fadok VA, Henson PM, Bratton DL. (2002). Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 26:404-412.
18. Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, Yoshioka K, Yoshika Y. (1997). Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 109:458-463.
19. Kimura A, Naka T, Kishimoto T. (2007). IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA 104:12099-12104.
20. Laan M, Lötvall J, Chung KF, Lindén A. (2001). IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 133: 200-206.
21. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234.
22. Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y. (2001). Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 276:26107-26113.
23. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, Sturrock RD, Wilkinson PC, Liew FY. (1996). The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2:175-182.
24. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. (1997). Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3:189-195.
25. McInnes IB, Liew FY. (1998). Interleukin 15: A proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 19:75-79.
26. Miyamoto M, Prause O, Sjötrand M, Laan M, Lötvall J, Lindén A. (2003). Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170:4665-4672.
27. Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Sato G, Ito K, Okudaira H. (1996). IL-15 promotes cytokine production of human T helper cells. J Immunol 156:2400-2405.
28. Mortier E, Bernard J, Plet A, Jacques Y. (2004). Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 173:1681-1688.
29. Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE. (1998). Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 101:1261-1272.
30. Park MK, Her YM, Cho ML, Oh HJ, Park EM, Kwok SK, Ju JH, Park KS, Min DS, Kim HY, Park SH. (2011). IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Immunol Lett 139:42-51.
31. Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M. (2005). The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 26:48-51.
32. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. (2003). Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741-2749.
33. Ŕkert R, Brandt K, Braun A, Hoymann HG, Herz U, Budagian V, D́kop H, Renz H, Bulfone-Paus S. (2005). Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol 174:5507-5515.
34. Sebbag M, Parry SL, Brennan FM, Feldmann M. (1997). Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol 27:624-632.
35. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. (1996). IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329-336.
36. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. (1996). Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 15:4928-4939.
37. Thurkow EW, van der Heijden IM, Breedveld FC, Smeets TJ, Daha MR, Kluin PM, Meinders AE, Tak PP. (1997). Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol 181:444-450.
38. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. (1996). Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34-40.
39. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. (2006). TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
40. Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, van de Winkel JG. (2003). Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112:1571-1580.
41. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, Jöres A. (2000). IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 165:5814-5821.
42. Woolley DE, Tetlow LC. (2000). Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2:65-74.
43. Wynn TA. (2003). IL-13 effector functions. Annu Rev Immunol 21:425-456.